BioCorRx (BICX) News Today $0.52 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period May 16, 2024 | finance.yahoo.comBioCorRx Reports Business Update for the First Quarter of 2024April 18, 2024 | finance.yahoo.comBioCorRx Inc. (BICX)April 3, 2024 | seekingalpha.comBioCorRx receives new patent for novel compound to treat pain, depression, and schizophreniaApril 3, 2024 | globenewswire.comBioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and SchizophreniaApril 2, 2024 | globenewswire.comBioCorRx Reports Business Update for 2023February 29, 2024 | msn.comHow to Win a Business Grant: 4 Entrepreneurs Share Their TipsFebruary 28, 2024 | globenewswire.comBioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUDFebruary 22, 2024 | benzinga.comBIOCORRX INC NEW by BioCorRx Inc. Stock (OTC:BICX), Quotes and News SummaryFebruary 13, 2024 | nz.finance.yahoo.comBioCorRx Inc. (BICX) stock price, news, quote & history – Yahoo FinanceFebruary 8, 2024 | finance.yahoo.comBioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of DirectorsJanuary 18, 2024 | msn.comCollective Audience And 3 Other Stocks Under $1 Insiders Are BuyingJanuary 9, 2024 | finance.yahoo.comBioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as PresidentJanuary 4, 2024 | seekingalpha.comTAYNX Transamerica High Yield ESG-Class R4January 3, 2024 | investing.comCheng Fwa Industrial Ltd (5426)November 16, 2023 | finanznachrichten.deBioCorRx Inc: BioCorRx Reports Business Update for the Third Quarter of 2023November 14, 2023 | finance.yahoo.comBioCorRx Reports Business Update for the Third Quarter of 2023October 3, 2023 | benzinga.comBioCorRx President Awarded $14K Worth of Stock OptionsAugust 21, 2023 | finanznachrichten.deBioCorRx Inc: BioCorRx Reports Business Update for the Second Quarter of 2023August 15, 2023 | finance.yahoo.comBioCorRx Submits Expanded Access Treatment Protocol to FDA for BICX104, Implantable Biodegradable Naltrexone Pellet for Treatment of Opioid Use DisorderAugust 14, 2023 | finance.yahoo.comBioCorRx Reports Business Update for the Second Quarter of 2023July 29, 2023 | investing.comTokai Holdings Corp (3167)July 29, 2023 | investing.comFukui Bank Ltd (8362)July 28, 2023 | investing.comNissha Printing Co Ltd (7915)July 18, 2023 | investing.comDSC Investment Inc (241520)July 18, 2023 | finance.yahoo.comBioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use DisorderMay 16, 2023 | finanznachrichten.deBioCorRx Inc: BioCorRx Provides Business Update for the First Quarter of 2023May 16, 2023 | finance.yahoo.comBioCorRx Provides Business Update for the First Quarter of 2023April 3, 2023 | finance.yahoo.comBioCorRx Provides Business Update for 2022March 7, 2023 | finance.yahoo.comBioCorRx Announced Interim Positive Safety and Pharmacokinetic Results of Phase 1 Clinical Trial at 4th Annual NIH HEAL Initiative Investigator MeetingJanuary 27, 2023 | finance.yahoo.comBioCorRx to Present at Sequire Biotechnology Conference on February 2ndJanuary 19, 2023 | finance.yahoo.comBioCorRx Announces Completion of Treatment Phase of Study Subjects and Preliminary Safety Data from Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use DisorderDecember 7, 2022 | finance.yahoo.comBioCorRx Partners with Government Plus to Expand its Beat Addiction Recovery Program in the United StatesNovember 22, 2022 | finance.yahoo.comBioCorRx Board of Directors Approves Exploration of Potential Spin-Off of BioCorRx Pharmaceuticals, Inc.November 15, 2022 | finanznachrichten.deBioCorRx Inc: BioCorRx Provides Business Update for the Third Quarter of 2022November 15, 2022 | finance.yahoo.comBioCorRx Provides Business Update for the Third Quarter of 2022October 24, 2022 | finance.yahoo.comBioCorRx to Present at the LD Micro Main Event XV on October 25thOctober 20, 2022 | finance.yahoo.comBioCorRx to Participate at the LD Micro Main Event XVOctober 13, 2022 | finance.yahoo.comBioCorRx Completes Final Subject Enrollment in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use DisorderSeptember 29, 2022 | nz.finance.yahoo.com2B3D Shares Addiction Treatment Deliverables from BioCorRx for Phase I of Mental Health Metaverse Platform BetaSeptember 16, 2022 | finance.yahoo.comBICX: Pivotal trial underwaySeptember 6, 2022 | apnews.comBioCorRx to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceSeptember 4, 2022 | reuters.comBICX.PK - Biocorrx Inc | Stock Price & Latest News | ReutersAugust 16, 2022 | finance.yahoo.comBioCorRx Provides Business Update for the Second Quarter of 2022July 13, 2022 | finance.yahoo.comBioCorRx to Participate in the Benzinga All Access Event on July 15thJuly 6, 2022 | finance.yahoo.comBioCorRX Inc. Discusses BICX104 Human Trials and 2B3D Metaverse Partnership with The Stock Day PodcastJune 30, 2022 | finance.yahoo.comBioCorRx Announces First Subject Dosed in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use DisorderJune 17, 2022 | finance.yahoo.comBioCorRx Featured on LiveNOW from FOXMay 31, 2022 | finance.yahoo.comBioCorRx to Present at the LD Micro Invitational XII on June 7thMay 19, 2022 | finance.yahoo.comBioCorRx and 2B3D to Pilot First-of-its-Kind PTSD and Addiction Treatment Solutions for Veterans in Metaverse SettingMay 17, 2022 | finance.yahoo.comBioCorRx Business Update for the First Quarter of 2022 Get BioCorRx News Delivered to You Automatically Sign up to receive the latest news and ratings for BICX and its competitors with MarketBeat's FREE daily newsletter. Email Address Rare signal predicts 50% market drop - before election (Ad)The market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED will cut rates any day now. But there's one indicator that's flashing a BIG warning sign to investors. Take these 4 steps to protect your retirement here. BICX Media Mentions By Week BICX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BICX News Sentiment▼0.000.61▲Average Medical News Sentiment BICX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BICX Articles This Week▼00▲BICX Articles Average Week Get BioCorRx News Delivered to You Automatically Sign up to receive the latest news and ratings for BICX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AIH News Today BACK News Today ACHC News Today BIXT News Today ICU News Today NICXF News Today SLGL News Today APRE News Today AWH News Today EVGN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BICX) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCorRx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCorRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
